OXANPRIME – OXANDROLONE 10MG/50pills- Eminence Labs India

32.00

OXANPRIME is employed with a diet program to cause weight gain in folks that have lost an excessive amount of weight thanks to surgery, injury, chronic (long-lasting) infections, trauma, or United Nations agency area unit weedy for unknown reasons.

Eminence Labs India

Free worldwide shipping on all orders over €300

  • Only original prodycts
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Description

OXANPRIME – Eminence Labs India

COMPOSITION: EACH UNCOATED TABLETS

CONTAINS: OXANDROLONE 10 MG

PRESENTATION : 2 Blister of 25 Tablets each in One Mono Carton with pack Insert

OXANPRIME is employed with a diet program to cause weight gain in folks that have lost an excessive amount of weight thanks to surgery, injury, chronic (long-lasting) infections, trauma, or United Nations agency area unit weedy for unknown reasons.

Oxanprime is additionally wont to treat bone pain in folks with pathology (a condition during which the bones become skinny and weak and break easily) and to forestall sure facet effects in folks that take corticosteroids (a cluster of medicines wont to treat several conditions that involve inflammation or swelling of a part of the body) for an extended time. Oxanprime is in an exceedingly category of medicines referred to as steroid hormone hormones. It works by increasing the number of supermolecule created by the body. This supermolecule is employed to make additional muscle and increase weight.

This medication is employed to assist folks regain weight they need lost thanks to sure medical conditions (such as surgery, chronic infection, trauma, future use of steroid medication like hydrocortisone/prednisone). it’s conjointly wont to relieve bone pain thanks to bone loss (osteoporosis). These medicine area unit like male hormones created by the body.

Reviews

There are no reviews yet.

Be the first to review “OXANPRIME – OXANDROLONE 10MG/50pills- Eminence Labs India”

Your email address will not be published. Required fields are marked *